Moreover, another study demonstrated that the combination of PRMT5 and PRMT1 inhibitors is synergistic in AML due to the inhibition of the arginine methylation of a large compendium of RBPs40. The gene discussed is PRMT1; the disease is acute myeloid leukemia.